Publications by authors named "A S Pannala"

Article Synopsis
  • 5-Fluorouracil (5-FU) is a chemotherapy drug with low oral absorption and severe side effects when given intravenously, so researchers explored using topical microemulsions (MEs) to reduce these side effects.
  • The study developed 5-FU MEs using a continuous manufacturing process called the Twin Screw Process (TSP), resulting in small particles that were confirmed to be effective for skin application without causing significant irritation.
  • In tests on skin cancer treatment in rats, the 5-FU MEs demonstrated sustained drug release and effectiveness against squamous cell carcinoma, showcasing the advantages of this new preparation method over traditional techniques.
View Article and Find Full Text PDF

Several therapeutically active molecules are poorly water-soluble, thereby creating a challenge for pharmaceutical scientists to develop an active solution for their oral drug delivery. This study aimed to investigate the potential for novel polymer-surfactant-based formulations (designated A and B) to improve the solubility and permeability of curcumin. A solubility study and characterization studies (FTIR, DSC and XRD) were conducted for the various formulations.

View Article and Find Full Text PDF

The development of liposome-nanoparticle colloid systems offers a versatile approach towards the manufacture of multifunctional therapeutic platforms. A strategy to encapsulate small metallic nanoparticles (<4nm) within multilamellar vesicles, effected by exploiting electrostatic interactions was investigated. Two liposome-gold nanoparticle (lipo-GNP) systems were prepared by the reverse-phase evaporation method employing cationic or anionic surface functionalised particles in combination with oppositely charged lipid compositions with subsequent post-formulation PEGylation.

View Article and Find Full Text PDF

Recent warnings by regulatory bodies and a product recall by the FDA have generated much interest in the area of dose dumping from controlled-release opioid analgesic formulations when coingested with alcohol. It was the aim of this study to address this issue and in doing so, gain understanding on how alcohol-induced effects may be avoided. In this study, tramadol release from Ultram ER tablets and T-long capsules was significantly increased in the presence of ethanol.

View Article and Find Full Text PDF

The major urinary metabolite of nitrotyrosine is 3-nitro-4-hydroxyphenylacetic acid (3-Nitro-HPA). However, recent animal studies have shown that the majority of urinary 3-Nitro-HPA is derived from nitration of endogenous para-hydroxyphenylacetic acid (HPA), a metabolite of tyrosine. One potential site for the formation of 3-Nitro-HPA is the stomach, where nitrous acid is formed by the reaction of nitrite in saliva with gastric acid.

View Article and Find Full Text PDF